Pileri A - Search Results

1

Alpha-2b recombinant interferon (Intron-A) as maintenance treatment in multiple myeloma.

Avvisati G, Petrucci MT, Pulsoni A, Tribalto M, Lauta VM, Gernone A, Boccadoro M, Marmont F, Pileri A, Dammacco F, et al. Avvisati G, et al. Among authors: pileri a. Eur J Haematol Suppl. 1990;52:9-11. doi: 10.1111/j.1600-0609.1990.tb00897.x. Eur J Haematol Suppl. 1990. PMID: 2279547 Clinical Trial. No abstract available.

2

Multiple myeloma: intensified maintenance therapy with recombinant interferon-alpha-2b plus glucocorticoids.

Palumbo A, Boccadoro M, Garino LA, Gallone G, Frieri R, Pileri A. Palumbo A, et al. Among authors: pileri a. Eur J Haematol. 1992 Aug;49(2):93-7. doi: 10.1111/j.1600-0609.1992.tb00037.x. Eur J Haematol. 1992. PMID: 1397246 Clinical Trial.

3

Recombinant interferon alfa-2b (Intron A) as post-induction therapy for responding multiple myeloma patients. M84 protocol.

Mandelli F, Tribalto M, Avvisati G, Cantonetti M, Petrucci MT, Boccadoro M, Pileri A, Marmont F, Resegotti L, Lauta V, et al. Mandelli F, et al. Among authors: pileri a. Cancer Treat Rev. 1988 Jan;15 Suppl A:43-8. doi: 10.1016/0305-7372(88)90073-4. Cancer Treat Rev. 1988. PMID: 3277709 Clinical Trial. No abstract available.

4

Standard chemotherapy for myelomatosis: an area of great controversy.

Boccadoro M, Pileri A. Boccadoro M, et al. Among authors: pileri a. Hematol Oncol Clin North Am. 1992 Apr;6(2):371-82. Hematol Oncol Clin North Am. 1992. PMID: 1582979 Review.

5

Consolidation treatment with dexamethasone and alpha-2B recombinant interferon further reduces the M-component level in multiple myeloma patients responding to conventional induction chemotherapy.

Palumbo AP, Garino AL, Frieri R, Gallone G, Boccadoro M, Pileri A. Palumbo AP, et al. Among authors: pileri a. Haematologica. 1990 Nov-Dec;75(6):576-8. Haematologica. 1990. PMID: 2098302

6

Advances in biology of multiple myeloma: cell kinetics, molecular biology and immunology.

Pileri A, Ferrero D, Massaia M, Dianzani U, Boccadoro M. Pileri A, et al. Eur J Haematol Suppl. 1989;51:30-4. doi: 10.1111/j.1600-0609.1989.tb01489.x. Eur J Haematol Suppl. 1989. PMID: 2697592 Review.

7

Cell kinetics of multiple myeloma.

Boccadoro M, Pileri A. Boccadoro M, et al. Among authors: pileri a. Hematol Pathol. 1987;1(3):137-42. Hematol Pathol. 1987. PMID: 3334345 Review. No abstract available.

8

Recombinant interferon-gamma inhibits the in vitro proliferation of human myeloma cells.

Palumbo A, Battaglio S, Napoli P, Omedè P, Fusaro A, Bruno B, Boccadoro M, Pileri A. Palumbo A, et al. Among authors: pileri a. Br J Haematol. 1994 Apr;86(4):726-32. doi: 10.1111/j.1365-2141.1994.tb04821.x. Br J Haematol. 1994. PMID: 7918064

9

Classification of patients affected by multiple myeloma using a neural network software.

Bugliosi R, Tribalto M, Avvisati G, Boccardoro M, de Martinis C, Friera R, Mandelli F, Pileri A, Papa G. Bugliosi R, et al. Among authors: pileri a. Eur J Haematol. 1994 Mar;52(3):182-3. doi: 10.1111/j.1600-0609.1994.tb01312.x. Eur J Haematol. 1994. PMID: 8168599 Clinical Trial. No abstract available.

10

Multiple myeloma: a tailored therapy for elderly patients.

Pileri A, Palumbo A, Boccadoro M. Pileri A, et al. Hematol Oncol. 1993;11 Suppl 1:67-72. Hematol Oncol. 1993. PMID: 8486344 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

438 results

Search Page

Filters